Band, Margaret MSumukadas, DeepaStruthers, Allan DAvenell, AlisonDonnan, Peter TKemp, Paul RSmith, Karen THume, Cheryl LHapca, AdrianWitham, Miles D2018-01-262018-01-262018-01-04Band, M M, Sumukadas, D, Struthers, A D, Avenell, A, Donnan, P T, Kemp, P R, Smith, K T, Hume, C L, Hapca, A & Witham, M D 2018, 'Leucine and ACE inhibitors as therapies for sarcopenia (LACE trial) : study protocol for a randomised controlled trial', Trials, vol. 19, 6. https://doi.org/10.1186/s13063-017-2390-91745-6215PubMedCentral: PMC5753568ORCID: /0000-0003-4813-5628/work/167120279http://hdl.handle.net/2164/9948This project is funded by the Efficacy and Mechanism Evaluation (EME) Programme, an MRC and NIHR partnership (grant number 13/53/03). The views expressed in this publication are those of the author(s) and not necessarily those of the MRC, NHS, NIHR or Department of Health. The authors acknowledge the financial assistance and support of the NIHR Ageing Clinical Research Network and acknowledge support from the Chief Scientist Office, Scottish Government Support for Science funding stream. The Health Services Research Unit is core funded by the Chief Scientist Office of the Scottish Government Health and Social Care Directorates.901053engJournal Articleolder peopleperindoprilleucinesarcopeniaphysical functionquality of liferandomised controlled trialR MedicineMedical Research Council (MRC)13/53/03National Institute for Health Research (NIHR)13/53/03Chief Scientist Office (CSO)RJournal article10.1186/s13063-017-2390-919